Aislinn Antrim, Managing Editor

Sunvozertinib is an oral, potent EGFR exon20ins inhibitor with wild-type EGFR selectivity.

The biosimilar is expected to be launched as a prefilled syringe in early 2023.

Results from the TOPAZ-1 phase 3 trial showed that the combination reduced risk of death by 20% versus chemotherapy alone.

With these bivalent vaccine authorizations, the monovalent mRNA COVID-19 vaccines are still not authorized as booster doses for individuals 12 years of age and older.

The vaccine candidate is composed of 2 preF proteins selected to optimize protection against the RSV A and B strains.

The companies are prepared to deliver doses of the Omicron-adapted bivalent vaccine for September, pending authorization.

Pharmacy Times will be covering the National Association of Chain Drug Stores (NACDS) Total Store Expo, taking place in Boston from August 27 to 29, 2022.

The announcement marks the first protein-based COVID-19 vaccine authorized in the United States for this patient population.

Auvelity uses the first new oral mechanism of action for major depressive disorder in more than 60 years.

Participants who initiated treatment with Biktarvy demonstrated superior hepatitis B virus (HBV) DNA suppression and HBV e-antigen seroconversion.

Ranibizumab-eqrn is the only biosimilar approved for all 5 Lucentis indications.

Ustekinumab is the first and only biologic that targets both cytokines interleukin (IL)-12 and IL-23.

Expanded indication for Rebinyn could allow patients with hemophilia B to participate in physical and social activities.

Along with expanding responsibilities, pharmacies must have the infrastructure and pharmacy staff must have sufficient support.

The increase in prescriptions for non-opioid pain medications coincided with a significant drop in opioid prescribing over the same period.

Progression-free survival was longer with brentuximab vedotin and fewer patients with Hodgkin lymphoma in this group received subsequent therapy.

The results showed a 38.1% confirmed objective response rate among HER2-positive patients who received tucatinib in combination with trastuzumab.

The FDA granted the vaccine series Emergency Use Authorization on July 14, based on clinical trial data showing significant efficacy and safety.

Organizations such as the Appalachian Community Cancer Alliance are working to leverage technology and improve barriers to care.

Some anti-abortion laws may lead to legal action against health care providers who prescribe or provide medications that can be used to induce abortions.

Screening participation increased over time, but the increase was smallest among individuals aged 50 to 54.

The non-estrogen pill was first approved by the FDA in 1973.

Health Mart also presented the first ever Innovation Award at McKesson ideaShare 2022.

Emphasizing the accessible nature of pharmacies and why this is essential for patients can help legislators and others understand why changes are necessary.

Harnessing the current momentum and engaging with legislators is crucial for the pharmacy industry to grow and expand.

Women in pharmacy must realize that what they have to offer has value, both to the business and to patients’ lives.

Finding the time to improve payer performance can be a major hurdle but designating even 30 minutes per week can make a difference.

Simple changes to each day can improve motivation and wellness for pharmacists.

Findings suggest that the HER2 L755S mutation plays a role in the aggressiveness of lobular breast cancer observed in the clinic.

Autologous stem cell transplantation was underutilized in community settings for mantle cell lymphoma.